@article{ref1,
title="Mortality rates among substance use disorder participants in clinical trials: pooled analysis of twenty-two clinical trials within the national drug abuse treatment clinical trials network",
journal="Journal of substance abuse treatment",
year="2016",
author="Lindblad, Robert and Hu, Lian and Oden, Neal and Wakim, Paul and Rosa, Carmen and VanVeldhuisen, Paul",
volume="70",
number="",
pages="73-80",
abstract="Background Most substance use disorders (SUD) treatment clinical trials are too short and small to reliably estimate the incidence of rare events like death.  Objective The aim of this study is to estimate the overall mortality rates among a SUD treatment-seeking population by pooling participants from multiple clinical trials conducted through the National Institute on Drug Abuse (NIDA)-sponsored National Drug Abuse Treatment Clinical Trials Network (CTN).  Highlights  •Standardized mortality (SM) rate among substance abuse trials was assessed. •Standardized mortality (SM) ratio among substance abuse trials was assessed. •SM rate of substance abuse trial population is higher than general population. •SM ratio of substance abuse trial population is higher than general population. <p /> <p>Language: en</p>",
language="en",
issn="0740-5472",
doi="10.1016/j.jsat.2016.08.010",
url="http://dx.doi.org/10.1016/j.jsat.2016.08.010"
}